📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
🔄 Reverse Split
55%
• 50-day avg $0.08 below $1 exchange minimum
📉 Score Deterioration
50%
• Score rose 44 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$6.91M
Shares Outstanding40.65M
Float26.14M
Cash$3.0K
Debt$96.9K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest222.0K
Days to Cover2.6
% of Float0.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for BVAXF
📊 BVAXF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BVAXF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.